NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LifeSprout

LifeSprout

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.lifesproutbio.com/

Last Round

Series A

Apr 27, 2020

Total Funding Raised

$35.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

LifeSprout is a biotechnology company that develops synthetic soft tissue substitutes for use in aesthetic and reconstructive medicine to facilitate tissue regeneration and repair.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Fashion & Beauty, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicinedermal fillerbiomaterial technologytissue scaffoldaesthetic medicinebiotechfacial rejuvenationbio-fillermedical deviceregenerative aestheticstissue engineeringbiomimeticsclinical-stage biotechbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LifeSprout Comparables

Compare LifeSprout with similar companies based on industry and business-model similarity.

LifeSprout comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spiderwort
82%
Tiger Biosciences
79%
MTF Biologics
77%

LifeSprout Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 27, 2020
SeedMay 29, 2019
SeedMar 21, 2018

LifeSprout Investors

Notable investors and investment history

LifeSprout investors
InvestorRounds
Redmile GroupSeries A
Emerald Development ManagersSeries A
Abell FoundationSeries A, Seed
TEDCOSeed
Kairos VenturesSeed
AngelMDSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 63% MoM, reaching 1.8K.

  • Apr 27, 2020

    $29M round led by Redmile Group.

LifeSprout Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LifeSprout Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LifeSprout's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range20
Year Founded2015
Last FundingApr 27, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.